Albireo Reports Third Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. CRWV
2. NVDA
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. RXRX
10. NOW

Go back to Albireo Reports Third Quarter 2018 Financial Results

Albireo Pharma (ALBO) Reports Q3 Loss of $1.17, Revenues Miss

November 13, 2018 7:03 AM EST

Albireo Pharma (NASDAQ: ALBO) reported Q3 EPS of ($1.17), versus $0.00 reported last year. Revenue for the quarter came in at $237 thousand versus the consensus estimate of $1.27 million.

With our Phase 3 clinical trial of A4250 for progressive familial intrahepatic cholestasis (PFIC) progressing... More